NCT02322216View on ClinicalTrials.gov

Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Olopatadine Hydrochloride Ophthalmic Solution 0.2%

DRUG

Olopatadine Hydrochloride Ophthalmic Solution 0.1%

DRUG

Olopatadine 0.2% Vehicle

Inactive ingredients used as placebo comparator

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT02322216 - Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects | Biotech Hunter | Biotech Hunter